Penn Researchers Awarded $10 Million Grant To Study Link Between Genes And,,Hormone-Related Cancers

(Philadelphia, PA) -- Whether taken to counteract menopausal symptoms with hormone replacement therapy or as oral contraceptives to prevent pregnancy, external hormones can increase the risk of breast and uterine cancers. To advance the investigation of hormone-induced female cancers, researchers at the University of Pennsylvania School of Medicine have been awarded a five-year Program Project Grant by the National Cancer Institute totaling nearly $10 million. This study has been dubbed by the investigators as "WISE: Women's Insights and Shared Experiences."

While female hormones can be risk factors for select cancers, a woman's genetic make-up may also affect her response to hormone exposures and the development of hormone-sensitive cancers. "The study's main objectives are to identify who is genetically susceptible to developing breast and uterine cancers, and to determine whether the anti-estrogen steroid progestin can help offset the increased risk of uterine cancers when added to traditional hormone replacement therapy, which consists of estrogen alone," explains Brian L. Strom, MD, MPH, principal investigator of the study and Chair of the Department of Biostatistics and Epidemiology at Penn. "A better understanding of the interaction between hormones and genetic mechanisms will have a great impact on how female cancers are addressed."

The $9.9 million WISE study combines the expertise of pharmacoepidemiologists, genetic epidemiologists, and molecular biologists to examine the relationships among hormone exposures, inherited susceptibility, and the genetic consequences of these exposures in the development of hormone-sensitive female cancers. The study is composed of three inter-related projects; two of which are population-based to ensure representation of the entire population and to eliminate selection bias.

The two population-based projects involve the random selection of women diagnosed with breast or uterine cancer from the entire Phi

Contact: Diane Giaccone
University of Pennsylvania School of Medicine

Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:

(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
(Date:3/30/2017)... YORK , March 30, 2017 Trends, ... type (physiological and behavioral), by technology (fingerprint, AFIS, iris ... voice recognition, and others), by end use industry (government ... and immigration, financial and banking, and others), and by ... Europe , Asia Pacific , ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... ... wash is a basic first aid supply for any work environment, but most personal eye ... first if a dangerous substance enters both eyes? It’s one less decision, and likely quicker ... eye piece. , “Whether its dirt and debris, or an acid or alkali, getting anything ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/10/2017)... DIEGO, CALIF. (PRWEB) , ... October 10, 2017 , ... ... as part of its corporate rebranding initiative announced today. The bold new look ... its reach, as the company moves into a significant growth period. , It will ...
(Date:10/10/2017)... firm Parks Associates announced today that Tom Kerber , ... Meeting , October 11 in Scottsdale, Arizona . Kerber ... smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction ...
Breaking Biology Technology:
Cached News: